Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma

Year of publication

2021

Authors

Matasar, Matthew J.; Dreyling, Martin; Leppä, Sirpa; Santoro, Armando; Pedersen, Michael; Buvaylo, Viktoriya; Fletcher, Monique; Childs, Barrett H.; Zinzani, Pier Luigi

Organizations and authors

University of Helsinki

Leppä Sirpa

Helsinki University Hospital

Leppä Sirpa

Publication type

Publication format

Article

Parent publication type

Journal

Article type

Original article

Audience

Scientific

Peer-reviewed

Peer-Reviewed

MINEDU's publication type classification code

A1 Journal article (refereed), original research

Publication channel information

Journal/Series

Clinical lymphoma myeloma and leukemia

Parent publication name

Clinical Lymphoma, Myeloma and Leukemia

Volume

Issue

Pages

E886-E894

ISSN

2152-2669

Publication forum

53602

Publication forum level

Open access

Open access in the publisher’s service

Yes

Open access of publication channel

Partially open publication channel

License of the publisher’s version

CC BY NC ND

Self-archived

Yes

License of the self-archived publication

CC BY NC ND

Other information

Fields of science

Cancers

Keywords

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Publication country

United States

Internationality of the publisher

International

Language

English

International co-publication

Yes

Co-publication with a company

Yes

DOI

10.1016/j.clml.2021.06.021

The publication is included in the Ministry of Education and Culture’s Publication data collection

Yes